How do you manage a patient with a nonspecific platelet function disorder and heterozygous protein C deficiency during pregnancy?

Assuming platelet function testing was done as part of a more comprehensive assessment of hemostasis and that there are no other detectable hemostatic defects (e.g., low von Willebrand factor level prior to 3rd trimester), I would not recommend giving DDAVP unless the patient has a significant bleed...